BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

161 related articles for article (PubMed ID: 30287926)

  • 21. [Clinicopathologic features of pleomorphic rhabdomyosarcoma].
    Yu L; Wang J
    Zhonghua Bing Li Xue Za Zhi; 2013 Mar; 42(3):147-52. PubMed ID: 23769431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myocardial rhabdomyoma with rhabdomyoblastic moiety.
    Bosman C; Boldrini R; Ballerini L; Baldini D; Marcelletti C
    Gen Diagn Pathol; 1996 May; 141(5-6):393-8. PubMed ID: 8780940
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Angiomatoid "malignant" fibrous histiocytoma: a clinicopathologic study of 158 cases and further exploration of the myoid phenotype.
    Fanburg-Smith JC; Miettinen M
    Hum Pathol; 1999 Nov; 30(11):1336-43. PubMed ID: 10571514
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Does alveolar soft-part sarcoma exhibit skeletal muscle differentiation? An immunocytochemical and biochemical study of myogenic regulatory protein expression.
    Wang NP; Bacchi CE; Jiang JJ; McNutt MA; Gown AM
    Mod Pathol; 1996 May; 9(5):496-506. PubMed ID: 8733764
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Myoglobin, desmin and vimentin in ultrastructurally proven rhabdomyomas and rhabdomyosarcomas. An immunohistochemical study utilizing a series of monoclonal and polyclonal antibodies.
    Seidal T; Kindblom LG; Angervall L
    Appl Pathol; 1987; 5(4):201-19. PubMed ID: 3689591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Clinicopathologic features of 300 rhabdomyosarcomas with emphasis upon differential expression of skeletal muscle specific markers in the various subtypes: A single institutional experience.
    Rekhi B; Gupta C; Chinnaswamy G; Qureshi S; Vora T; Khanna N; Laskar S
    Ann Diagn Pathol; 2018 Oct; 36():50-60. PubMed ID: 30098515
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pulmonary "Inflammatory Leiomyosarcomas" Are Indolent Tumors With Diploid Genomes and No Convincing Rhabdomyoblastic Differentiation.
    Kao YC; Kuo CT; Kuo PY; Huang HY; Lu TP; Hsieh TH; Fletcher CDM; Lee JC
    Am J Surg Pathol; 2022 Mar; 46(3):424-433. PubMed ID: 35175969
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SRF-FOXO1 and SRF-NCOA1 Fusion Genes Delineate a Distinctive Subset of Well-differentiated Rhabdomyosarcoma.
    Karanian M; Pissaloux D; Gomez-Brouchet A; Chevenet C; Le Loarer F; Fernandez C; Minard V; Corradini N; Castex MP; Duc-Gallet A; Blay JY; Tirode F
    Am J Surg Pathol; 2020 May; 44(5):607-616. PubMed ID: 32187044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Are myogenin and myoD1 expression specific for rhabdomyosarcoma? A study of 150 cases, with emphasis on spindle cell mimics.
    Cessna MH; Zhou H; Perkins SL; Tripp SR; Layfield L; Daines C; Coffin CM
    Am J Surg Pathol; 2001 Sep; 25(9):1150-7. PubMed ID: 11688574
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Malignant peripheral nerve sheath tumors: prognostic impact of rhabdomyoblastic differentiation (malignant triton tumors), neurofibromatosis 1 status and location.
    Kamran SC; Howard SA; Shinagare AB; Krajewski KM; Jagannathan JP; Hornick JL; Ramaiya NH
    Eur J Surg Oncol; 2013 Jan; 39(1):46-52. PubMed ID: 23084090
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Primary cutaneous sarcomas showing rhabdomyoblastic differentiation.
    Wong TY; Suster S
    Histopathology; 1995 Jan; 26(1):25-32. PubMed ID: 7713481
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Fusion-driven Spindle Cell Rhabdomyosarcomas of Bone and Soft Tissue: A Clinicopathologic and Molecular Genetic Study of 25 Cases.
    Dehner CA; Broski SM; Meis JM; Murugan P; Chrisinger JSA; Sosa C; Petersen M; Halling KC; Gupta S; Folpe AL
    Mod Pathol; 2023 Oct; 36(10):100271. PubMed ID: 37422156
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pleomorphic rhabdomyosarcoma in children: four cases in the pediatric age group.
    Furlong MA; Fanburg-Smith JC
    Ann Diagn Pathol; 2001 Aug; 5(4):199-206. PubMed ID: 11510002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potential utility of CD5 immunohistochemical staining in the diagnosis of muscle tumors.
    McNab PM; DeMers NM; Schlauder S; Morgan M; Nasir A; Coppola D; Bui MM
    Ann Clin Lab Sci; 2009; 39(2):108-13. PubMed ID: 19429795
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Rhabdomyosarcoma in middle to old-aged patients: analysis of clinicopathological features and prognosis in 76 cases].
    Yu L; Wang J
    Zhonghua Zhong Liu Za Zhi; 2012 Dec; 34(12):910-6. PubMed ID: 23336377
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Genital rhabdomyoma of the urethra in an infant girl.
    Lu DY; Chang S; Cook H; Alizadeh Y; Karam AK; Moatamed NA; Dry SM
    Hum Pathol; 2012 Apr; 43(4):597-600. PubMed ID: 21992817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Sclerosing rhabdomyosarcoma of the parotid gland: Unusual location of a rare mesenchymal tumor].
    Bacha D; Chaabane A; Charfi L; Douggaz A; Kilani H; Chelbi E
    Ann Pathol; 2021 Feb; 41(1):123-128. PubMed ID: 32713625
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Uterine mixed embryonal rhabdomyosarcoma and fetal rhabdomyoma.
    Jacques SM; Lawrence WD; Malviya VK
    Gynecol Oncol; 1993 Feb; 48(2):272-6. PubMed ID: 8428702
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The current landscape of rhabdomyosarcomas: an update.
    Leiner J; Le Loarer F
    Virchows Arch; 2020 Jan; 476(1):97-108. PubMed ID: 31696361
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Histiocyte-rich rhabdomyoblastic tumor of the trunk.
    Frizzell MR; Nguyen NM; Parikh SA; Sinai MJ; Martin HL; Goldberg LH
    JAAD Case Rep; 2020 Oct; 6(10):1001-1002. PubMed ID: 32995429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.